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Ligands stimulate Notch receptors by inducing regu-
lated intramembrane proteolysis (RIP) to produce a
transcriptional effector. Notch activation requires un-
masking of a metalloprotease cleavage site remote
from the site of ligand binding, raising the question
of how proteolytic sensitivity is achieved. Here, we
show that application of physiologically relevant
forces to the Notch1 regulatory switch results in
sensitivity to metalloprotease cleavage, and bound
ligands induce Notch signal transduction in cells
only in the presence of applied mechanical force.
Synthetic receptor-ligand systems that remove the
native ligand-receptor interaction also activate
Notch by inducing proteolysis of the regulatory
switch. Together, these studies show that mechani-
cal force exerted by signal-sending cells is required
for ligand-induced Notch activation and establish
that force-induced proteolysis can act as a mecha-
nism of cellular mechanotransduction.
INTRODUCTION
Notch signaling conveys information between cells using a
mechanism that is conserved in organisms ranging from flies
to humans. These signals influence a wide range of cell fate de-
cisions both during development and in adult tissue homeosta-
sis. In addition, a number of human diseases are associated
with mutations of Notch pathway components that result in
loss or gain of function.
Notch signaling occurs when a transmembrane ligand of the
Delta, Serrate, and Lag2 (DSL) family engages a transmembrane
Notch receptor on a neighboring cell, inducing regulated intra-
membrane proteolysis (RIP) to produce a transcriptional effector
(Kopan and Ilagan, 2009). During transport to the cell surface,DevelNotch receptors are cleaved at site S1 by a furin-like protease,
but are resistant to further proteolysis, because the activating
cleavagesite, calledS2, is buried in anautoinhibitedconformation
within a negative regulatory region (NRR) consisting of three LNR
modulesanda juxtamembrane ‘‘heterodimerizationdomain’’ (HD)
(Gordon et al., 2007, 2009). Ligand binding relieves autoinhibition
by exposing S2 to ADAM metalloproteases (Brou et al., 2000;
Mumm et al., 2000). Activating mutations of the Notch1 NRR
that result in ligand-independent proteolysis are found frequently
in human leukemias, highlighting the importance of tight control of
metalloprotease access to the S2 site (Weng et al., 2004).
How ligand engagement relieves autoinhibition of Notch re-
mains poorly understood. X-ray structures of the NRRs from
Notch1 and Notch2 show that the S2 site near the C-terminal
end of the HD is masked by the LNRs (Gordon et al., 2007,
2009), indicating that ligand binding must result in sufficient
displacement of the LNRs to allow metalloprotease access to
S2. Because the binding site for Notch ligands is centered on
EGF repeats 11–12, more than 20 EGF modules away (Rebay
et al., 1991), and because genetic and biochemical studies
have established a requirement for endocytosis of ligand into
signal sending cells (Nichols et al., 2007; Musse et al., 2012), it
has long been speculated that endocytic internalization of
Notch-bound ligands delivers a pulling force that relieves autoin-
hibition by exposing S2 (Musse et al., 2012). It remains unknown,
however, whether S2 proteolysis can be induced in the physio-
logic force regime or whether force is even required to activate
ligand-bound receptors on cells.
In thework reported here, we develop a single-molecule assay
to determine the force required for NRR proteolysis in vitro, and
using a cell-based magnetic tweezer assay we also developed,
we show that force is required for relief of Notch autoinhibition
in cells. We also designed two synthetic ligand-receptor sys-
tems, which both show that signal-sending cells supply sufficient
force to induce metalloprotease sensitivity in the NRR in the
absence of native ligand-receptor interactions, indicating that
ligand binding does not need to exert an allosteric effect on
the sensitivity of the NRR in order for activating proteolysis to
occur. These results show that mechanical force generated byopmental Cell 33, 729–736, June 22, 2015 ª2015 Elsevier Inc. 729
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Figure 1. Single-Molecule Assay of
Adam17-Mediated Proteolysis of the
Notch1 NRR under Force
(A) Assay schematic and experimental design.
Magnetic beads are tethered to proteins immobi-
lized in a flow cell mounted on an inverted micro-
scope. Force is applied to the beads by varying the
distance between a magnet and the surface of the
flow cell. Substrate proteolysis is monitored by
determining the fraction of beads released over
time. The expanded view in the right panel illus-
trates the Notch1 NRR, captured on the flow cell
with streptavidin and tethered to the magnetic
bead using anti-SUMO antibodies.
(B) Adam17-catalyzed proteolysis of biotinylated
and SUMO tagged recombinant peptides, con-
taining either the natural S2-cleavage site
sequence (AV, green and pink), or a mutated
sequence with a V1721G substitution (AG, orange
and cyan) at the forces indicated.
(C) Adam17-catalyzed proteolysis of the Notch1
NRR, monitored as a function of time at different
levels of applied force. Traces shown represent
averages of two or three replicates.
(D and E) Effect of inhibitors on proteolysis of the
Notch1 NRR in the single molecule cleavage
assay. Traces shown represent a single experi-
ment. (D) Effect of WC629, an anti-Notch1 inhibi-
tory antibody that binds to the NRR, on the time
course of Adam17-catalyzed NRR proteolysis. (E)
Effect of BB94, an ADAM inhibitor, on the time
course of Adam17-catalyzed NRR proteolysis.
Additional control experiments are provided in
Figure S1.signal-sending cells is sufficient to unfold the NRR and sensitize
Notch to proteolytic activation.
RESULTS
Physiologic Forces Sensitize theNRR toADAMCleavage
To test whether proteolytic cleavage of the activation switch
occurs in a physiologic force regime, we developed a single-
molecule, multiplexed magnetic tweezers assay to determine
the proteolytic sensitivity of the isolated Notch1 NRR as a func-
tion of applied force (Figures 1 and S1). The Notch1 NRR, as well
as control proteins intrinsically sensitive or resistant to Adam17
cleavage, was immobilized on the surface of a flow cell by strep-730 Developmental Cell 33, 729–736, June 22, 2015 ª2015 Elsevier Inc.tavidin capture, tethered to magnetic
beads coated with an anti-SUMO anti-
body, and subjected to Adam17 deliv-
ered by syringe pump. Enzymatic
cleavage of tethered molecules was
determined as a function of applied mag-
netic force, monitoring bead loss by dark
field microscopy.
Proteolysis experiments using control
peptides show that Adam17 cleaves a
bead-tethered polypeptide that presents
the native S2 processing site of Notch1
(‘‘AV’’ peptide) when as little as 1 pN offorce is applied. The kinetics of cleavage for the AV peptide
are indistinguishable at 1 and 5.4 pN of applied force, already
fully sensitive to Adam17 at 1 pN. In contrast, a control peptide
with a mutated cleavage site (AG) is Adam17 resistant up to 7
pN of applied force (Figure 1B).
When the intact Notch1 NRR is examined in this assay, it
resists Adam17 cleavage at a force of 3.5 pN, but undergoes
proteolysis at forces R5.4 pN, indicating that the transition
from resistance to sensitivity occurs in a physiologically
accessible regime between 3.5 and 5.4 pN of force (Figures
1C and S1D). Both an NRR conformation-specific inhibi-
tory antibody WC629 and the metalloprotease inhibitor BB94
prevent proteolysis by Adam17, confirming that bead release
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Figure 2. Response of Cell-Surface Notch
Receptors to Applied Force using a Multi-
plexed Magnetic Tweezers Assay
(A) Experimental design. A plate containing 96 cy-
lindrical magnets is positioned over a 96-well plate
of cells in order to apply force to magnetic beads
tethered to Notch molecules on the cell-surface.
The distance between the cells and the magnet is
varied by using the polymer PDMS to create ter-
races of different heights.
(B) Assay schematic. Cells expressing Notch1 re-
ceptors in which the ankyrin-repeat domain has
been replaced by the Gal4 DNA-binding domain
(Malecki et al., 2006) are stimulated by magnetic
beads loaded with the ligand DLL4, followed by
measurement of luciferase reporter gene activity.
(C and D) Luciferase reporter gene activity in
response to various treatments as a function of the
distance from the magnet. U2OS cells expressing
Notch1-Gal4 receptors were incubated with mag-
netic beads alone or beads loaded with the ligand
DLL4 in the absence or presence of a gamma
secretase inhibitor (GSI) (C) or metalloprotease
inhibitor BB94 (D). Luciferase reporter gene activity
is reported relative to the response of cells to
beads alone at a distance of 4 mm from the mag-
net. Error bars represent the SEM of triplicate
measurements, and statistical significance was
determined with a two-way ANOVA followed by a
post hoc Bonferroni test. Magnet calibration (96-
well) is provided in Figure S2.results from metalloprotease cleavage at S2 (Figures 1D
and 1E).
Force Induces Notch Activation in Cells
We next wished to determine whether force is required for the in-
duction of a Notch signal when ligands bind to Notch receptors
on cells. Because studies using genetically encoded or surface
tethered force sensors have shown that signaling proteins
such as integrins (Morimatsu et al., 2013; Wang and Ha, 2013),
cadherins (Borghi et al., 2012), and vinculin (Grashoff et al.,
2010) respond to applied force in the 1–40 pN range, we devel-
oped a high-throughput magnetic tweezers assay to apply a
wide range of pN-scale forces to Notch receptors on the cell-sur-
face. Our method uses magnetic tweezers in 96-well format and
applies force to cell-surface receptor molecules bound to li-
gands on paramagnetic beads (Figure 2A). By controlling the dis-
tance between the cells and the magnet, it is possible to vary the
force applied to cells as a function of their well position on the
plate. In order to present the cells at different distances from
the magnet, we dispensed different amounts of PDMS polymer
into the culture chambers, creating a ‘‘terraced’’ configuration
of wells of different depths across the plate. The range of forces
sampled in a given experiment is specified simply by varying the
heights of the terraces, the size of the beads and the character-
istics of the magnet. For example, when 1 mm beads are used
and the distance of the magnet from the cells ranges from 0.15
to 0.5 mm, the applied force estimated from force calibration us-
ing phage lambda DNA ranges from 0.5 to 2.5 pN (see Figure S2
for 96-well magnet calibration).
To probe the force dependence of Notch activation using this
assay, we cultured cells expressing Notch1-Gal4 chimeric re-Develceptors (Malecki et al., 2006) in wells of different depths and
treated the cells with paramagnetic beads loaded with the ligand
DLL4. Force was applied to the beads by placing a 96-well mag-
net over the plate, and luciferase reporter-gene activity was
measured 6 hr later (Figure 2B). When cells expressing the
Notch1-derived receptors are incubated with DLL4-loadedmag-
netic beads, a statistically significant signal is induced only when
the magnet is%2.2 mm from the beads and is suppressed in the
presence of gamma-secretase or metalloprotease inhibitors
(Figures 2C and 2D). (This magnet distance exerts a force of
about 1.4 pN based on in vitro calibration with lambda DNA; Fig-
ure S2.) Given the many differences between the cell-based and
in vitro proteolysis assays, it is not surprising that the amount of
force sufficient to induce Notch proteolysis differs between the
two experiments. In particular, the sustained delivery of force
(over several hours) to receptors on cells combined with intrinsic
protein dynamic motions promoting conformational opening
likely results in irreversible capture of transiently open states
by proteolysis at reduced forces and accounts for the lower force
requirement in cells. Other factors, such as the influence of the
membrane or its microenvironment, the ligand-binding domain
of the receptor, or the clustering of receptors in response to
bead-tethered ligand, may also contribute. Regardless, the key
finding is that force must be applied to bead-tethered ligands
in order to induce the canonical proteolytic steps responsible
for Notch activation.
Robust Notch Signals in Synthetic Systems
To explore whether or not a signal-sending cell can directly
deliver sufficient force to induce NRR proteolysis, we created
‘‘synthetic’’ ligand-receptor signaling systems that substituteopmental Cell 33, 729–736, June 22, 2015 ª2015 Elsevier Inc. 731
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Figure 3. Development and Evaluation of
Two Synthetic Notch Signaling Systems
(A) Schematic comparing the natural human Notch-
ligand signaling system (top; EGF repeats 11–12
in red) to a synthetic signaling system placing
NRR proteolysis under rapamycin-inducible control
(bottom). Here, FKBP replaces the N-terminal
portionof DLL4, andFRB replacesEGF-like repeats
1–23 of Notch1. The Notch1 ankyrin domain is also
replaced with Gal4, as above (Malecki et al., 2006).
(B) Western blots monitoring receptor proteolysis.
U2OS cells stably expressing wild-type or FRB-
Notch1 were grown in the presence of the DLL4
ectodomain or FKBP immobilized on plastic tissue
culture dishes in the absence or presence of ra-
pamycin (100 nM) and/or a GSI (Compound E,
400 nM). Blots were probed with an antibody
directed against an epitope of intracellular Notch1
(a-TAD) or the a-V1744 antibody to S3-cleaved
Notch1 (Cell Signaling).
(C) Cell-based reporter gene assay. U2OS cells
stably transfected with the indicated Notch vari-
ants were co-cultured with 293T cells transiently
transfected with the indicated ligands. Luciferase
activity for each U2OS line is reported relative to
co-culture with 293T cells transfected with empty
vector. Error bars reflect the SE of readings per-
formed in triplicate. Additional control experiments
are provided in Figure S3.
(D) Schematic illustrating design of a GFP-GFP-
binding nanobody (GBN) synthetic ligand-receptor
pair. Full-length fly Serrate andNotch are shown for
reference.Theartificial ligandconsistsofGFP,CD8,
and the Serrate-derived tail. The ectodomain of the
Notch-derived molecule consists of the GFP bind-
ing nanobody (GBN) and the NRR, and the intra-
cellular domain contains theQF transcription factor,
the Notch PEST domain, and a triple Myc tag.
(E) Co-culture assay. S2R+ cells expressing GFP-
mcd8-Ser as ligand (green, upper left panel) were
co-cultured with cells expressing GBN-Fly-
Notch(NRR)-QF-3XMyc (GBN-N-QFMyc). Recep-
tor is stained with anti-myc antibody (magenta,
lower left panel). The tdTomato reporter signal is
red (upper right panel). DNA was stained with DAPI
(blue, lower right panel).
(F) QAS luciferase readout of cell-mixing experi-
ment. Luciferase reporter gene activity for the
GBN-Notch cell line is reported relative to co-cul-
ture with control cells. Error bars represent the SE
of measurements performed in quadruplicate.
See also Figure S3.the native binding interaction between Notch1 and DLL4 with
non-native interacting pairs to tether signal-sending and
receiving cells together. These systems dispense with native
interaction domains and thus eliminate the possibility that forma-
tion of a native ligand-receptor complex allosterically lowers the
barrier to proteolysis of the NRR.
In the first system, we tethered sending and receiving cells us-
ing the FRB domain of mTor and the FK506 binding protein
(FKBP), which interact to form a stable complex only in the pres-
ence of rapamycin (Figure 3A). The chimeric DLL4 ligand mole-
cules substitute FKBP in place of the Notch-binding MNNL
and DSL domains, but retain the rest of their extracellular region,732 Developmental Cell 33, 729–736, June 22, 2015 ª2015 Elsevier Ias well as the transmembrane region and cytoplasmic tail, which
contains the sequences that target the ligand for endocytosis.
The Notch-derived molecules substitute the FRB domain of
mTor in place of EGF-like repeats 1–23 that encompass the
ligand binding region, but retain repeats 24–36, the NRR, the
transmembrane region, and the Notch1-Gal4 intracellular fusion
for monitoring luciferase reporter activity with a Gal4 response
element as above (Figure 3A).
We first tested the fidelity of this synthetic ligand-receptor pair
and compared its signaling activity with normal ligand-receptor
complexes using a well-established ‘‘plated ligand’’ assay, in
which cells expressing receptors of interest are cultured innc.
dishes coated with a ligand ectodomain. Plated DLL4 (or plated
anti-HA) stimulates proteolytic activation of the intact HA-
Notch1-Gal4 fusion protein, but not the FRB-Notch1 chimera;
in contrast, plated FKBP, when in the presence of rapamycin, in-
duces proteolytic activation of the FRB-Notch1 chimera, but not
the standard Notch1-Gal4 fusion (Figures 3B and S3A).
We next tested whether this synthetic system signals in a co-
culture assay, in which ligand-expressing cells are used to stim-
ulate a signal in receptor-expressing cells (Figure 3C). Control
experiments confirm that DLL4 expressing cells induce a re-
porter response in the cells expressing full-length HA-tagged
Notch1, but not in cells expressing a truncated HA-tagged re-
ceptor, or the chimeric FRB-Notch receptor. In contrast, cells ex-
pressing the FKBP chimeric ligand only activate signaling in cells
expressing the FRB-Notch chimeric receptor in a rapamycin-
dependent fashion (Figure 3C). This signaling activity is sensitive
to a gamma secretase inhibitor and to themetalloprotease inhib-
itor BB94, indicating that activating proteolysis of the NRR at S2
and subsequent S3 cleavage can be triggered in the absence of
native receptor-ligand interactions. Similar results are obtained
when the experiment is performed with Notch molecules lacking
all 36 EGF repeats (Figure S3B).
We also created a second chimeric signaling system derived
from Drosophila proteins that pairs an anti-GFP nanobody and
the QF transcriptional activator under Notch NRR control with
a Serrate-derived protein that substitutes GFP (followed by
CD8) in place of the normal Serrate ectodomain (Figure 3D).
Thus, the entire ligand binding domain of Notch and the entire
Notch-binding region of the ligand have been removed. Never-
theless, this system induces expression of tomato-GFP (under
control of a QF-responsive element) only in nanobody-driven
responder cells that are in direct contact with GFP-expressing
ligand cells (Figures 3E and S3C) and signals in co-culture as-
says (Figure 3F). The robust signaling observed in two synthetic
systems utilizing non-native modes of protein-protein interaction
shows that a pair of interacting moieties sufficient to (1) bring
signal sending and receiving cells into contact, and (2) withstand
rupture under the force required to expose S2 is all that is needed
to induce NRR proteolysis and transduce a signal. Although the
native ligand-receptor interaction may alter the energy land-
scape associated with conformational exposure of the S2 site
of the NRR, the synthetic systems show conclusively that an
allosteric effect of ligand binding is not necessary for S2 cleav-
age to occur.
Endocytosis Is Required for S2 Site Exposure
To address whether or not endocytosis of the ligand is required
for proteolytic activation of the receptor, we blocked ligand
endocytosis in the mammalian and rapamycin-dependent co-
culture assays using two different approaches: (1) deletion of
the cytoplasmic tail of the ligand (which is required for endocy-
tosis-dependent activation), and (2) treatment of ligand-express-
ing cells with hydroxydynasore, a small-molecule endocytosis
inhibitor (McCluskey et al., 2013). The response to both interven-
tions in the rapamycin-based synthetic signaling system mirrors
that of Notch1 responding cells to DLL4-expressing signal-
sending cells. Tailless ligands, which are transported to the cell
surface as well as ligands with intact cytoplasmic tails (Fig-
ure S4), attenuate production of the gamma-secretase cleavedDevelproduct (Figure 4A) and reporter gene expression (Figure 4B).
Similarly, treatment of ligand cells with hydroxydynasore sup-
presses accumulation of the S3-cleaved product in both wild-
type Notch-DLL4 and synthetic signaling systems (Figure 4C).
Production of the S3-cleaved product is comparably attenuated
in both systems by treatment with a gamma-secretase inhibitor,
the metalloprotease inhibitor BB94, or the anti-Notch1 inhibitory
antibody WC75, which binds specifically to the Notch1 NRR and
stabilizes the autoinhibited conformation. Similar decreases in
signaling activity occur upon hydroxydynasore treatment in the
Drosophila GFP nanobody-GFP synthetic system (Figure 4D).
Together, these data show that endocytosis of ligands artificially
tethered to receptor molecules promotes proteolytic activation
of Notch signaling in a fashion that remains dependent on a
conformational change in the NRR permissive for S2 and S3
cleavages. Importantly, tethering alone without ligand endocy-
tosis is insufficient for activation.We conclude that a step depen-
dent on ligand endocytosis is required for signal-sending cells to
deliver sufficient mechanical force to the receptor to induce
the proteolytic cascade responsible for receptor activation and
downstream signaling events.
DISCUSSION
The goal of these studies was to gain insight into the still elusive
mechanism of ligand-induced proteolysis of Notch receptors.
Previous X-ray structures of the Notch NRR ‘‘activation switch’’
show that a major conformational change must occur in order
to unmask the solvent inaccessible S2 processing site for metal-
loprotease cleavage. A leading model (Parks et al., 2000) pro-
poses that endocytosis of ligands applies a pulling force to
bound Notch receptors, thereby exposing the S2 proteolytic
site. In this model, the NRR would then be a mechanosensitive
switch responding to this pulling force. A number of indirect lines
of evidence are consistent with themechanotransductionmodel,
and the requirement for a specialized pathway for endocytosis of
ligands in the signal-sending cells is well established (Musse
et al., 2012).
As appealing as a mechanotransduction model might be,
however, it has remained unclear (1) whether or not the force
required to induce proteolytic sensitivity in vitro or in vivo lies in
a physiologically accessible force regime, (2) whether allostery
is required to lower the barrier to proteolysis, and (3) whether
or not the force is delivered by ligand endocytosis. AFM studies
in which the Notch2 NRR was pulled under high loading rates
showed that multiple unfolding transitions occur in the 100 pN
range, but how these findings relate to a physiological context
is unclear (Stephenson and Avis, 2012). Studies using plated li-
gands conjugated to tension-gated tethers (TGT), which sense
forces imposed on cellular receptors based on rupturing short
DNA duplexes, led to the conclusion that Notch activation oc-
curs at forces under 12 pN, but could not establish whether or
not applied force was needed at all because of the limits of
DNA duplexes as force sensors (Wang and Ha, 2013). The use
of plate-bound ligands as activators also does not address
whether or not signal-sending cells are capable of supplying
an activating force.
Here, we developed assays to determine how the proteolytic
sensitivity of site S2 varies as a function of applied force bothopmental Cell 33, 729–736, June 22, 2015 ª2015 Elsevier Inc. 733
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Figure 4. Analysis of Natural and Synthetic Notch Receptor Signaling in Co-culture Assays
(A) Effect of ligand-tail deletion on signaling. Wild-type and synthetic Notch receptors were co-cultured with full-length or tail-deleted cognate ligands (Ligand-
tailless) and in the absence or presence of rapamycin (250 nM), as indicated. Blots were probed with an antibody directed against an epitope of intracellular
Notch1 (a-TAD), or the a-V1744 antibody to S3-cleaved Notch1 (Cell Signaling).
(B) Cell-based reporter gene assay probing Notch activation in co-culture experiments. 293T cells were signal-sending cells, and U2OS cells were signal-
receiving cells. 293T cells were transfected with plasmids encoding wild-type Dll4, tailless Dll4, FKBP-Dll4, FKBP-Dll4-tailless, or empty vector in the presence or
absence of rapamycin (250 nM), Compound E (GSI, 400nM), or BB94 (20 mM). U2OS cells were transfected in 96-well format with plasmids encoding HA-Notch1-
Gal4 (left), or FRB-Notch1-Gal4 (right) along with a luciferase reporter plasmid containing the Gal4 response element and an internal control plasmid expressing
Renilla luciferase. Twenty-four hours after transfection, the 293T cells were added to the U2OS cells. Luciferase activity relative to the Renilla control was
determined 24 hr later. Fold activation is relative to U2OS cells transfected with HA-Notch1-Gal4 and co-cultured with empty-vector transfected 293T cells. Error
bars represent the SE of triplicate measurements.
(C) Effect of various drug or antibody treatments on signaling by wild-type or synthetic receptors when co-cultured with cognate ligands. Blots were probed with
a-TAD or the a-V1744 antibody as in (A).
(D) Effect of hydroxydynasore in the fly synthetic signaling assay. Ligand expressing cells and untransfected control cells were first treated with the indicated
concentration of H-Dynasore for 30 min. Receptor and ligand (or control) cells were then mixed together in a 1:5 ratio. Fresh drug was added to maintain the
desired concentration, and luciferase activity was determined 6 hr later. Trypan blue staining after 10 hr of co-culture showed no difference in viability between
DMSO and drug treatment (not shown).
See also Figure S4.in vitro and in cells under physiologically relevant conditions.
The in vitro magnetic tweezers assay revealed that the isolated
activation switch undergoes a transition from protease resis-
tance to sensitivity between 3.5 and 5.4 pN of force. Typical
rate constants of cleavage were63 103M1s1, in line with re-
ported catalytic efficiencies for the isolated metalloprotease
domain of Adam17 (Caescu et al., 2009). Cell-surface Notch1 re-
ceptors also exhibit mechanosensitivity upon application of
force via ligand tethered magnetic beads, as the presence of734 Developmental Cell 33, 729–736, June 22, 2015 ª2015 Elsevier Iligand-coated beads alone is not sufficient to induce Notch
activation.
The low forces required to relieve Notch autoinhibition show
that the NRR is a highly mechanosensitive switch. How do these
forces compare to the forces required for unfolding of other me-
chanosensors, or for other biological force-dependent events?
The A2 domain of von Willebrand factor, a mechanosensor
that undergoes proteolysis in response to shear stress, unfolds
with a transition at 8 pN of force (Zhang et al., 2009). Similarly,nc.
the binding of vinculin to talin relies on unfolding in the talin R3
domain over a force range of 2–5 pN (del Rio et al., 2009;
Yao et al., 2014). In addition, the force required for S2 exposure
is comparable to the 3–4 pN force generated by a myosin motor
taking a step on actin (Finer et al., 1994) and stall forces
measured for kinesin (4–6 pN) and dynein (1 pN) (Blehm et al.,
2013). Importantly, the force required to relieve autoinhibition
of the activation switch is lower than the forces measured by op-
tical tweezers to rupture ligand-receptor interactions and in line
with the measured stall force generated by endocytosis of
DLL1 (Meloty-Kapella et al., 2012; Shergill et al., 2012) and
with the force experienced by EGFR during endocytosis (Stabley
et al., 2012). Our data using synthetic signaling systems now
show that allostery is not required to render the NRR sensitive
to proteolytic activation. Moreover, these experiments directly
link ligand-receptor engagement to proteolytic site exposure of
the NRR in a step that depends on ligand endocytosis, though
whether or not endocytosis itself supplies the pulling force re-
mains to be determined.
Our studies investigating the responsiveness of the Notch1
NRR to force also raise a number of newquestions about theme-
chanosensitive behavior of Notch receptors. What degree of
domain movement is required to relieve autoinhibition? Is the
barrier to mechanical exposure of the metalloprotease site in
Notch1 influenced by the EGF-repeat region, or is the mechano-
sensitive property of the entire receptor completely encoded
within the NRR?How do lateral interactions among Notch recep-
tors in the membrane affect receptor mechanosensitivity? And
how does the intrinsic sensitivity to force vary among the various
Notch receptors, both in isolation, in response to disease-asso-
ciated mutations, different ligands, or mechanical forces gener-
ated in the cellular microenvironment (e.g., by blood flow ormus-
cle contraction)?
The methods developed here to investigate the role of Notch
signaling should havewide utility for exploring the consequences
of Notch signal transduction under precise chemical and tempo-
ral control and for investigation of other mechanosensitive
processes in biology. The synthetic GFP-nanobody and rapamy-
cin-dependent signaling systems open up new possibilities for
controlling and reporting on Notch activation in a defined cellular
context. The approaches can be used to investigate the kinetics
of metalloprotease recruitment, receptor proteolysis, as well as
events downstream of receptor cleavage. The assays can also
report on whether or not two cells contact each other in vivo.
Finally, the cell-based magnetic tweezers assay should facilitate
new studies of other biological processes that may rely on me-
chanical force for the induction of signaling, such as ephrin-eph-
rin receptor signaling (Salaita et al., 2010), atypical cadherin
complexes of the inner ear (Sotomayor et al., 2012), and other
transmembrane signaling events.
EXPERIMENTAL PROCEDURES
Materials
A complete description of constructs, recombinant proteins, and cell lines are
provided in the Supplemental Experimental Procedures.
Single-Molecule Magnetic Tweezer Experiments
Briefly (see Supplemental Experimental Procedures), single-molecule experi-
ments were performed using custom microfluidic flow cells with glass cover-Develslips as described previously (Tanner and van Oijen, 2010). Two stacked
6-mm cube magnets were attached to a mount containing a micrometer in or-
der to control the distance from the magnet to the flow cell. Biotinylated NRRs
or peptides are delivered into the flowcell with a syringe pump and captured in
the flowcell with streptavidin. After delivery of magnetic beads followed by
extensive washing, buffer with Adam17 (1 mM), and ZnCl2 (4 mM) was added.
Movies were recorded using Metavue or MicroManager in 1-s increments
for up to 30 min. The total number of beads in each frame (103 objective)
was counted using a built-in algorithm in ImageJ. For NRR experiments,
Adam17 was loaded into the flow cell at 1 pN force, and the magnet subse-
quently lowered to the appropriate distance corresponding to the desired
applied force. The magnet calibration is described in Supplemental Experi-
mental Procedures.
96-Well Magnetic Tweezer Assays
PDMS Components A and B (Sylgard 184, Dow Corning) were added to a
50 ml falcon tube in a ratio of 10:1 and were mixed by slow rotation over
30 min. The mixture was centrifuged at 4,000 3 g for 5 min and then
dispensed with an Eppendorf digital repeat pipette using the slowest setting
to ensure reproducible dispensing. The PDMS was dispensed into 96-well
TC-coated plates in volume ‘‘steps’’ from 40–120 ml and was cured over-
night at 37C. Before cells were plated, the wells were bathed in 70 ml of
fibronectin (10 mg/ml in PBS; Sigma) for 1 hr at 37C. U2OS cell lines stably
expressing Flag-Notch1-Gal4 were then reverse-transfected with luciferase
reporter plasmids as above, treated with 1 mM doxycycline to induce protein
expression, and plated onto the PDMS-modified wells. After 24–48 hr,
cells were incubated in DMEM with or without 500 nM recombinant
Dll4 ectodomain (R&D Systems). After 20 min, an excess of 1 mm IMAC
magnetic beads in DMEM (Dynal) was added, and a plate with the 96-well
configuration of magnets was placed over the cells (Alpaqua). The level of
luciferase reporter activity was determined 6 hr later using a Promega
Dual Luciferase kit.
Chimeric Notch/Ligand Experiments
Co-culture experiments, human cell lines. On day 1, Notch1-Gal4 fusion con-
structs and reporter plasmids were reverse transfected into U2OS cells in 96-
well format as above. Ligand molecules were reverse transfected separately
into 293T cells in 6-well plates (2 mg ligand/well) using Lipofectamine 2000.
On day 2, ligand-transfected cells were resuspended in fresh DMEM with
10% FBS, drugs were added as indicated, and the 293T cells were plated
on top of the Notch-expressing cells. On day 3, the luciferase reporter activity
was determined as above.
Co-culture experiments, Drosophila cell lines. On day 1, S2R+ cells were
transfected in 6-well dishes with 400 ng total DNA/well using Effectene
Transfection Reagent (QIAGEN). Receptor positive cells were generated
by transfection of 396 ng of QUAT::tdTomato and 4 ng ubi::GBN-fly-
Notch(NRR)-QF-3XMyc DNA. Ligand-positive cells were generated by trans-
fection of 100 ng Actin::Gal4 together with 300 ng UAST::GFP-mcd8-Ser or
UAS-GFP-mcd8-Dl. On day 3, receptor and ligand positive cells were each
washed in fresh culture medium to remove transfection reagents and dis-
lodged from dishes by pipetting. Half of the receptor positive cells were
mixed with ligand positive cells, while the other half were mixed with the
same number of untransfected S2R+ cells (control). The cell mixture was
transferred into a 1.5 ml Eppendorf tube and slowly rotated at room temper-
ature for 1 hr to allow the ligand and receptor positive cells to bind to each
other. Then the cell mixture was plated back into a new 6-well dish and
cultured for one additional day before assay. For immunofluorescence imag-
ing, the cell mixture was plated on coverglass bottom chamber slides (Lab-
Tek) coated with Concanavalin-A. Cells were fixed in 4% formaldehyde,
stained with mouse anti-Myc antibody (1:400, 9E10, Santa Cruz Biotech) fol-
lowed by Alexa 647 goat anti-mouse IgG (1:500, Invitrogen), and observed
after mounting in a Zeiss LSM 780 confocal microscope using a 633/N.A.
1.4 oil objective. Western blot methods are provided in Supplemental Exper-
imental Procedures.
Statistical analysis of reporter assays. Error bars in reporter assays repre-
sent SEM of triplicate or quadruplicate measurement. Statistical analysis to
assess significance (p values) was performed with GraphPad Prism software
using two-way ANOVA followed by a Bonferroni post hoc test.opmental Cell 33, 729–736, June 22, 2015 ª2015 Elsevier Inc. 735
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